The incidence of early-onset cancers is not rising overall, but rates of certain cancers are increasing among younger patients, new data suggest.

Delgocitinib cream is more effective and has a better safety profile than oral alitretinoin for the treatment of severe chronic hand eczema.

Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

The FDA has accepted the New Drug Application for berotralstat as prophylactic therapy for pediatric patients aged 2 to 11 years with hereditary angioedema.

Lower neighborhood socioeconomic status is associated with a greater risk for new hidradenitis suppurativa diagnosis.

Many head and neck cancer survivors felt that they lacked knowledge on topics including mental health, diet and exercise, smoking, and more.

The USPSTF has reaffirmed their 2018 recommendation for early, universal syphilis screening in pregnant patients based on new studies.

Guselkumab treatment was associated with improvements in 3 biomarkers associated with systemic inflammation among patients with plaque psoriasis.

Microneedling was associated with greater rates of treatment adherence than medication alone in patients with androgenetic alopecia.

Dupilumab and omalizumab are both effective adjuvant treatments for adults with bullous pemphigoid, though dupilumab may provide better outcomes.

Icotrokinra led to high rates of skin clearance in patients with scalp and genital psoriasis, according to results from the ICONIC-TOTAL study.

An estimated 18,968,894 American children lived with at least one parent with a substance use disorder in 2023.